Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00689377

Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention — PANDORA  

Peripheral Arterial Disease (PAD) Clinical Trial

Official title:
Prevalence of Peripheral Arterial Disease in Subjects With a Moderate CVD Risk, With No Overt Vascular Diseases nOR diAbetes Mellitus

Clinical Trial Summary

Non interventional study aimed to establish the prevalence of lower extremity peripheral arterial disease (PAD), defined as an ankle-brachial index (ABI) not above 0.90 in subjects with a moderate risk of cardiovascular disease, with no overt cardiovascular diseases nor diabetes mellitus.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00689377
Study type Observational
Source AstraZeneca
Contact
Status Completed
Phase N/A
Start date May 2007
Completion date July 2008
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01175850 - Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease N/A
Active, not recruiting NCT00707876 - Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD) Phase 2
Completed NCT00760565 - A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD). Phase 1
Recruiting NCT04631848 - ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease
Completed NCT00196066 - Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS) Phase 2
Recruiting NCT05834673 - VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) Phase 4
Recruiting NCT05498740 - Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia N/A
Completed NCT02780349 - Evaluation of WIRION™ EPS in Lower Extremities Arteries N/A
Completed NCT02254837 - Zilver PTX Post-Market Study in Japan N/A
Completed NCT02254356 - Zilver Flex Post-Market Study in Japan N/A
Active, not recruiting NCT05149664 - A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD N/A
Recruiting NCT04749732 - Home-based Exercise Therapy for Patients With PAD N/A
Completed NCT02936622 - Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses N/A
Completed NCT00827619 - Zilver® Flex™ Vascular Stent Study N/A
Completed NCT00862420 - Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease Phase 3
Completed NCT04753372 - Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk
Not yet recruiting NCT06457685 - Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial N/A
Recruiting NCT05246410 - A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. N/A
Terminated NCT03111238 - The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM Phase 3
Terminated NCT03174522 - The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM Phase 3